Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis

NCT: NCT01765374 · COMPLETED

NCT IDNCT01765374
StatusCOMPLETED
Start Date2011-02
Completion2014-10

Brief Summary

To detect by sonography relapse of disease activity prior to clinical symptoms in RA patients treated by rituximab.

Frequently Asked Questions

What is Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis?

Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis is a clinical trial registered under NCT01765374. Current status: COMPLETED.

What is the status of NCT01765374?

The current status of NCT01765374 (Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis) is: COMPLETED.

When did Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis start?

Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis started on 2011-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑